Clinical Trial
Spasmolytic properties of dantrolene sodium: clinical evaluation
- PMID: 804674
Item in Clipboard
Clinical Trial
Spasmolytic properties of dantrolene sodium: clinical evaluation
Mil Med.
1975 Jan.
No abstract available
Similar articles
-
A comparison of dantrolene sodium and diazepam in the treatment of spasticity.Paraplegia. 1974 Nov;12(3):170-4. doi: 10.1038/sc.1974.27. Paraplegia. 1974. PMID: 4616209 Clinical Trial. No abstract available.
-
Dantrolene sodium in children with spasticity.Arch Phys Med Rehabil. 1974 Aug;55(8):384-8. Arch Phys Med Rehabil. 1974. PMID: 4604292 Clinical Trial. No abstract available.
-
Letter: Treatment of spasticity in multiple sclerosis with dantrolene.JAMA. 1975 Sep 8;233(10):1046. JAMA. 1975. PMID: 1099254 Clinical Trial. No abstract available.
-
Clinical assessment and pharmacologic therapy of spasticity.Arch Phys Med Rehabil. 1974 Aug;55(8):344-54. Arch Phys Med Rehabil. 1974. PMID: 4277407 Review. No abstract available.
-
Electromyographic investigation of spasticity and muscle spasm.Physiotherapy. 1976 Oct;62(10):319-23. Physiotherapy. 1976. PMID: 790427 Review. No abstract available.
Cited by
-
Dantrolene sodium: a review of its pharmacological properties and therapeutic efficacy in spasticity.Drugs. 1977 Jan;13(1):3-23. doi: 10.2165/00003495-197713010-00002. Drugs. 1977. PMID: 318989 Review.
-
Anti-spasticity agents for multiple sclerosis.Cochrane Database Syst Rev. 2000;2003(4):CD001332. doi: 10.1002/14651858.CD001332. Cochrane Database Syst Rev. 2000. Update in: Cochrane Database Syst Rev. 2001;(4):CD001332. doi: 10.1002/14651858.CD001332. PMID: 11034714 Free PMC article. Updated.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources